Metastatic pattern and response to endocrine therapy in human breast cancer

Breast Cancer Research and Treatment
C Kamby, C Rose


The effect of endocrine therapy in 465 postmenopausal patients with advanced breast cancer who entered four consecutive, randomized trials has been related to the site of the metastases. Patients received either tamoxifen (T) alone or T in combination with medroxyprogesterone acetate, diethylstilbestrol, halotestin, or aminoglutethimide. The overall response rate was 40%. Responses were most frequently seen in patients with metastases in soft tissue, and the duration of response to endocrine therapy in these patients was longer than for those with metastases in bone or viscera (p less than 0.00001). In addition, the response rate was inversely correlated with the number of main metastatic sites in patients with soft tissue metastases, whereas the response rate was not associated with the number of metastatic sites in patients with metastases in bone and viscera. Survival after first recurrence was significantly longer in responding patients with soft tissue lesions compared to those with recurrence in bone or viscera. In contrast, survival after first recurrence was identical in patients with nonresponding disease, irrespective of dominant site of metastases. The outcome of endocrine therapy depends partially upon the dominant ...Continue Reading


Jan 1, 1976·Annals of Surgery·A SinghakowintaV K Vaitkevicius
Feb 4, 1979·Biochimica Et Biophysica Acta·E Roos, K P Dingemans
Dec 1, 1984·Archives of Internal Medicine·R QaziW Drobyski
Jan 1, 1984·The American Journal of Medicine·S M de la MonteG W Moore
Jan 1, 1980·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·C RoseH T Mouridsen
Jul 1, 1980·International Journal of Radiation Oncology, Biology, Physics·S H Levitt, R A Potish
Sep 1, 1981·British Journal of Cancer·F C CampbellJ L Haybittle
Apr 1, 1981·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J F StewartJ L Hayward


Mar 1, 1988·European Journal of Cancer & Clinical Oncology·C KambyK Zedeler
Jan 1, 1993·Breast Cancer Research and Treatment·L E StenbygaardP Dombernowsky
Jan 1, 1992·Acta Oncologica·C KambyH T Mouridsen
Aug 1, 1994·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·R I Schiff

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Radiologic Clinics of North America
H I LibshitzG D Dodd
Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
A Chrapowicki
Breast Cancer : the Journal of the Japanese Breast Cancer Society
Masakazu OguraMasahiro Hiraoka
© 2021 Meta ULC. All rights reserved